Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Crown Holdings | CCK | 25. mar 2025 | 87.15 | -1.40 |
Crown LNG | CGBS | 25. mar 2025 | 0.24 | +2.43 |
Cryo-Cell International | CCEL | 25. mar 2025 | 6.38 | +0.16 |
CryoPort | CYRX | 25. mar 2025 | 6.24 | -12.11 |
CS Disco | LAW | 25. mar 2025 | 4.47 | -0.89 |
CSG Systems International | CSGS | 25. mar 2025 | 60.74 | -0.65 |
CSP | CSPI | 25. mar 2025 | 15.78 | -5.96 |
CSW Industrials | CSWI | 25. mar 2025 | 306.80 | +1.55 |
CSX | CSX | 25. mar 2025 | 29.53 | -1.07 |
CTO Realty Growth | CTO | 25. mar 2025 | 19.13 | -0.93 |
CTO Realty Growth A Pref | CTO-A | 25. mar 2025 | 21.34 | -0.74 |
CTRL Group | MCTR | 25. mar 2025 | 7.53 | 0.00 |
CTS | CTS | 25. mar 2025 | 43.67 | -0.34 |
CubeSmart | CUBE | 25. mar 2025 | 41.07 | -1.58 |
Cue Biopharma | CUE | 25. mar 2025 | 1.00 | -3.29 |
Cullen Frost Bankers B Pref | CFR-B | 25. mar 2025 | 17.87 | +0.22 |
Cullen/Frost Bankers | CFR | 25. mar 2025 | 125.34 | -0.51 |
Cullinan Therapeutics | CGEM | 25. mar 2025 | 8.30 | -2.81 |
Culp | CULP | 25. mar 2025 | 5.24 | -0.95 |
Cumberland Pharmaceuticals | CPIX | 25. mar 2025 | 4.33 | -1.59 |
Cummins | CMI | 25. mar 2025 | 330.87 | -0.06 |
Cumulus Media A | CMLS | 25. mar 2025 | 0.49 | +0.41 |
Curbline Properties | CURB | 25. mar 2025 | 23.54 | -0.68 |
Curevac N.V. | CVAC | 25. mar 2025 | 2.91 | -3.00 |
CuriosityStream | CURI | 25. mar 2025 | 3.13 | +7.75 |
Curis | CRIS | 25. mar 2025 | 2.50 | -3.85 |
CURRENC Group | CURR | 25. mar 2025 | 1.69 | -5.06 |
Curtiss-Wright | CW | 25. mar 2025 | 339.49 | +0.97 |
Cushing Mlp & Infrastructure Total Return Fund | SRV | 25. mar 2025 | 44.84 | +0.76 |
Cushman & Wakefield | CWK | 25. mar 2025 | 10.66 | -1.20 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.